Back
Adaptimmune Therapeutics PLC Vs. Autolus Therapeutics PLC Industry Stock Comparison
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.63
Seasonality Move:
50.57%
Sell
50
AUTL
Autolus Therapeutics PLC
Last Price:
2.84
Seasonality Move:
0.84%
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
Autolus Therapeutics PLC (AUTL)
is a Sell
Is Autolus Therapeutics PLC a Buy, Sell or Hold?
- The current Autolus Therapeutics PLC [AUTL] share price is $2.80. The Score for AUTL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AUTL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
AUTL Stock Price Chart
What is Autolus Therapeutics PLC's stock price today?
-
The Autolus Therapeutics PLC share price today is $2.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 38.6 | Sell |
| Chaikin Money Flow: | -1006052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 0.83) | Sell |
| Bollinger Bands (100): | (0.81 - 1.21) | Sell |
AUTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 31.51 | Sell |
| Chaikin Money Flow: | -1097781 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.17 - 4.39) | Sell |
| Bollinger Bands (100): | (3.51 - 4.37) | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Sell |
| 20-day SMA: | 0.74 | Sell |
| 50-day SMA: | 0.86 | Sell |
| 200-day SMA: | 1.12 | Sell |
| 8-day EMA: | 0.68 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 0.84 | Sell |
| 200-day EMA: | 1 | Sell |
AUTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.12 | Sell |
| 20-day SMA: | 3.58 | Sell |
| 50-day SMA: | 3.82 | Sell |
| 200-day SMA: | 4.47 | Sell |
| 8-day EMA: | 3.11 | Sell |
| 20-day EMA: | 3.45 | Sell |
| 50-day EMA: | 3.74 | Sell |
| 200-day EMA: | 4.1 | Sell |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.11 per share.
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Autolus Therapeutics PLC Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||